BASF opens applications laboratory for pharmaceutical industry in India

11-Dec-2008 - India

BASF has opened an applications laboratory for pharmaceutical excipients and active ingredients in Mumbai, India. The aim is to move even closer to customers in the key markets of the Asia-Pacific region. The new laboratory will allow BASF to meet the requirements of the pharmaceutical industry for technical support more quickly. Customers will not only be provided with advice about functional aspects when choosing products, such as the excipients Kollidon®, Kollicoat®, Cremophor® and Lutrol®. BASF experts in the laboratory will also help in optimizing formulations and improving production conditions.

“We want to make even more improvements in the global range of products and services we offer our customers”, says Martin Widmann, who is responsible for BASF’s global Pharma Ingredients & Services business unit. “The new applications laboratory in Mumbai is an important milestone in achieving this aim.”

In Asia, the pharmaceutical industry has grown particularly through the strong market position of generics. South and South-East Asia have a key role to play here. "The pharmaceutical manufacturers in the region are operating on an increasingly global basis now. This is presenting our customers' local research and development facilities with huge challenges, such as those associated with new systems for releasing active ingredients", says Ralf Fink, head of the regional BASF business unit Pharma Ingredients & Services in Asia.

The new laboratory is integrated into the existing research and development facilities of BASF India Ltd. in Mumbai. It is provided with state-of-the-art equipment allowing all the production processes that are relevant for solid dosage forms, such as granulation, tabletting and coating, to be carried out. In addition, the laboratory also has a wide range of measuring equipment, which can be used to analyze fundamental parameters within the processes. Finished tablets can also be tested for friability, dissolution, disintegration or color deviations.

https://www.bionity.com/en/news/91985/basf-opens-applications-laboratory-for-pharmaceutical-industry-in-india.html